|
TUBE1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.11259999999269E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.624140E-04 |
| Normal-vs-Stage2 |
2.423000E-03 |
| Normal-vs-Stage3 |
3.13129999707229E-09 |
| Normal-vs-Stage4 |
1.346350E-02 |
| Stage1-vs-Stage2 |
7.490800E-01 |
| Stage1-vs-Stage3 |
7.194200E-04 |
| Stage1-vs-Stage4 |
6.132000E-01 |
| Stage2-vs-Stage3 |
4.792400E-02 |
| Stage2-vs-Stage4 |
7.906800E-01 |
| Stage3-vs-Stage4 |
3.189400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.92747999999687E-05 |
| Normal-vs-AfricanAmerican |
1.323950E-03 |
| Normal-vs-Asian |
5.382300E-02 |
| Caucasian-vs-AfricanAmerican |
9.387200E-01 |
| Caucasian-vs-Asian |
6.969600E-02 |
| AfricanAmerican-vs-Asian |
1.747630E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.759860E-04 |
| Normal-vs-Female |
3.26279999995904E-06 |
| Male-vs-Female |
9.679800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.405100E-04 |
| Normal-vs-Age(41-60Yrs) |
2.44510000002585E-06 |
| Normal-vs-Age(61-80Yrs) |
1.615790E-04 |
| Normal-vs-Age(81-100Yrs) |
1.680860E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.125900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.363600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.002830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.144600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.453000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.425000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.5848000000096E-06 |
| Classical-VS-Follicular |
2.139000E-03 |
| Classical-VS-Other |
5.599800E-01 |
| Classical-VS-Normal |
2.23579999999446E-05 |
| Tall-VS-Follicular |
3.22329996027548E-09 |
| Tall-VS-Other |
5.418100E-02 |
| Tall-VS-Normal |
1.61649582608447E-11 |
| Follicular-VS-Other |
6.803600E-01 |
| Follicular-VS-Normal |
1.710580E-01 |
| Other-VS-Normal |
2.354200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.404560E-04 |
| Normal-vs-N1 |
9.710100E-02 |
| N0-vs-N1 |
5.464600E-01 |
|
|
